Open Access. Powered by Scholars. Published by Universities.®

Sports Medicine Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Sports Medicine

Measurement Of Upper Limb Range Of Motion Using Wearable Sensors: A Systematic Review, Corrin P. Walmsley, Sian A. Williams, Tiffany Grisbrook, Catherine Elliott, Christine Imms, Amity Campbell Jan 2018

Measurement Of Upper Limb Range Of Motion Using Wearable Sensors: A Systematic Review, Corrin P. Walmsley, Sian A. Williams, Tiffany Grisbrook, Catherine Elliott, Christine Imms, Amity Campbell

Faculty of Health Sciences Publications

Background: Wearable sensors are portable measurement tools that are becoming increasingly popular for the measurement of joint angle in the upper limb. With many brands emerging on the market, each with variations in hardware and protocols, evidence to inform selection and application is needed. Therefore, the objectives of this review were related to the use of wearable sensors to calculate upper limb joint angle. We aimed to describe (i) the characteristics of commercial and custom wearable sensors, (ii) the populations for whom researchers have adopted wearable sensors, and (iii) their established psychometric properties. Methods: A systematic review of literature was ...


Relationship Between Baseline Physical Activity Assessed By Pedometer Count And New-Onset Diabetes In The Navigator Trial, William E. Kraus, Thomas Yates, Jaakko Tuomilehto, Jie-Lena Sun, Laine Thomas, John Mcmurray, M. A. Bethel, Rury R. Holman Jan 2018

Relationship Between Baseline Physical Activity Assessed By Pedometer Count And New-Onset Diabetes In The Navigator Trial, William E. Kraus, Thomas Yates, Jaakko Tuomilehto, Jie-Lena Sun, Laine Thomas, John Mcmurray, M. A. Bethel, Rury R. Holman

Faculty of Health Sciences Publications

Objective
Physical activity is related to clinical outcomes, even after adjusting for body mass, but is rarely assessed in randomized clinical trials.
Research design and methods
We conducted an observational analysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial, in which a total of 9306 people from 40 countries with impaired glucose tolerance and either cardiovascular disease or cardiovascular risk factors were randomized to receive nateglinide or placebo, in a 2-by-2 factorial design with valsartan or placebo. All were asked to also participate in a detailed lifestyle modification programme and followed-up for a median ...